M. Clerici et al., NON-SMALL-CELL LUNG-CANCER TREATMENT WITH VINORELBINE MONOCHEMOTHERAPY - A PHASE-II STUDY, Anticancer research, 15(2), 1995, pp. 477-478
Non small cell lung cancer is one of the leading causes of death in th
e industrial countries and some 70% of patients have non surgically er
adicable disease. Platinum based combined regimens can achieve 35-40%
objective responses, but advanced age, low performance status and conc
urrent diseases can exclude up to 60% of patients from an adequate pol
iychemotherapy treatment.